Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05240131 |
| Title | A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC). |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Galecto Biotech AB |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Centre Georges Grancois Leclerc | Dijon | 21000 | France | Details | ||
| CHRU | Tours | 37044 | France | Details | ||
| Samodzielny Publiczny Zespol Gruzlicy I Chorob Pluc | Olsztyn | 10-357 | Poland | Details | ||
| Hospital Universitario y Politécnico La Fe | Valencia | València | 46026 | Spain | Details | |
| Hospital Universitari Vall d'Hebron | Barcelona | 08035 | Spain | Details |